QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer 期刊论文 2018, 卷号: 13, 期号: 10, 页码: 1539-1548 作者:  Wu, Yi-Long;  Lu, Shun;  Lu, You;  Zhou, Jianying;  Shi, Yuan-kai 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03 ALK-positive advanced non-small cell lung cancer  crizotinib  chemotherapy  phase III   Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer 期刊论文 2017, 卷号: 2, 期号: 3, 页码: e000219 作者:  Blackhall Fiona;  Ross Camidge D;  Shaw Alice T;  Soria Jean-Charles;  Solomon Benjamin J 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03 Alk  clinical trial  crizotinib  profile 1005   Phase 3 study of first-line crizotinib vs pemetrexed-cisplatin/carboplatin (PCC) in East Asian patients (pts) with ALK plus advanced non-squamous non-small cell lung cancer (NSCLC). 期刊论文 2016, 卷号: 34, 期号: 15 作者:  Lu, Shun;  Mok, Tony;  Lu, You;  Zhou, Jianying;  Shi, Yuankai 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 Phase 3 study of first-line crizotinib vs pemetrexed-cisplatin/carboplatin (PCC) in East Asian patients (pts) with ALK plus advanced non-squamous non-small cell lung cancer (NSCLC). 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20 作者:  Lu, Shun;  Mok, Tony;  Lu, You;  Zhou, Jianying;  Shi, Yuankai 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2012, 卷号: 30, 期号: 8 作者:  Bergethon, Kristin;  Shaw, Alice T.;  Ou, Sai-Hong Ignatius;  Katayama, Ryohei;  Lovly, Christine M. 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/19 PHARMACOKINETICS (PK) OF CRIZOTINIB (PF-02341066), A DUAL ALK/C-MET INHIBITOR, FOLLOWING ADMINISTRATION OF MULTIPLE ORAL DOSES TO PATIENTS WITH ADVANCED ALK-POSITIVE NSCLC IN CHINA 期刊论文 2012, 卷号: 7, 期号: 11, 页码: S491-S491 作者:  Tan, Weiwei;  O'Gorman, Melissa;  Lanzalone, S.;  Wilner, Keith;  Boyd, Jason 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13 crizotinib  pharmacokinetics  ALK  NSCLC   Visual effects in anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) patients treated with crizotinib. 期刊论文 2012, 卷号: 30, 期号: 15 作者:  Salgia, Ravi;  Solomon, Benjamin J.;  Shaw, Alice Tsang;  Camidge, D. Ross;  Evans, Tracey L. 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13 Visual effects in anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) patients treated with crizotinib. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2012-05-20 作者:  Salgia, Ravi;  Solomon, Benjamin J.;  Shaw, Alice Tsang;  Camidge, D. Ross;  Evans, Tracey L. 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13